Wednesday, October 1, 2025
HomeFundingApricot Raises Series A Funding

Apricot Raises Series A Funding

Apricot, the AI-native documentation platform transforming post-acute care, today announced its Series A funding round led exclusively by global software investor Insight Partners. The funding will accelerate hiring, product innovation, and go-to-market expansion.

“Apricot addresses the most expensive and painful problem in post-acute care: the SOC (Start of Care) visit,” said Trent Smith, Founder and CEO of Apricot. “The SOC visit is supposed to set the tone for care, yet it typically means close to two hours of a nurse tapping through hundreds of required fields and checkboxes while the patient waits for meaningful interaction.”

Read More – SolidCore.ai Raises $4M in Seed Funding

Smith continued, “Before founding Apricot, I started and ran my own home health and hospice agency for seven years. I saw firsthand, day in and day out, how painful this problem was for nurses, agencies, and patients. It’s not just inefficient—it undermines the very spirit of patient care. That’s why solving it is so personal for me.”

Apricot exists to change that dynamic. Its mission: free clinicians from hours of documentation so they can focus on patients, with user-friendly technology that ensures cleaner records, stronger compliance, and a more intimate clinician and patient experience.

The company began with SOC documentation because it’s the most complex and time-consuming part of home health. Addressing this challenge first allowed Apricot to build and refine a core product that delivers on the highest standards of compliance, reliability, and workflow integration. Today, Apricot’s platform is used by agencies ranging from regional operators to national leaders, proving its ability to scale across diverse care models.

The Series A marks Insight Partners’ first investment into an Oklahoma-based company. With this new funding, Apricot is preparing to release support for the remaining visit types in the post-acute space, including other OASIS, therapy, and routine visits.

Read More – Phaidra Raises Over $50M in Series B Funding

- Advertisement -
RELATED ARTICLES
- Advertisment -

Most Popular